MedPath

Hydrocortisone Acetate

Hydrocortisone Acetate Suppositories, 25 mg

Approved
Approval ID

df6203a0-25ec-472e-a117-58bc0842b698

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 1, 2022

Manufacturers
FDA

Cameron Pharmaceuticals, Limited Liability Company

DUNS: 078371442

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydrocortisone Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42494-341
Product Classification
G
Generic Name
Hydrocortisone Acetate
Product Specifications
Route of AdministrationRECTAL
Effective DateJuly 1, 2022
FDA Product Classification

INGREDIENTS (2)

Hydrocortisone AcetateActive
Quantity: 25 mg in 1 1
Code: 3X7931PO74
Classification: ACTIB
C10-18 TRIGLYCERIDESInactive
Code: 43AGM4PHPI
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hydrocortisone Acetate - FDA Drug Approval Details